Sequence information
Variant position: 178 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 396 The length of the canonical sequence.
Location on the sequence:
TPYAQRMERVLRENADSLQA
S LRPHADELKAKIDQNVEELK
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human TPYAQRMERVLRENADSLQAS LRPHADELKAKIDQNVEELK
TSHAQRMQSALRQNVDDLHSS LTPFADELKAKIDQNVEELK
Mouse TPYIQRMQTTIKENVDNLHTS MMPLATNLKDKFNRNMEELK
Rat TPYIQRMQTTIQDNVENLQSS MVPFANELKEKFNQNMEGLK
Pig KPYAERMESVLRQNIRNLEAS VAPYADEFKAKIDQNVEELK
Bovine TPYVERMEKVMRQNLDQLQAS LAPYAEELQATVNQRVEELK
Cat TSHAQRMEAVLRENVDNLQSS LTPYADEFKAKIDQNIEELK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Literature citations
Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.
Deeb S.S.; Nevin D.N.; Iwasaki L.; Brunzell J.D.;
Hum. Mutat. 8:319-325(1996)
Cited for: VARIANTS SEATTLE-3 SER-161; SEATTLE-1 LEU-178 AND SEATTLE-2 GLN-264;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.